These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 8863571

  • 1. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC, Hovey R, Carroll PR, Shinohara K.
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [Abstract] [Full Text] [Related]

  • 2. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.
    Cookson MS, Floyd MK, Ball TP, Miller EK, Sarosdy MF.
    J Urol; 1995 Sep; 154(3):1070-3. PubMed ID: 7543601
    [Abstract] [Full Text] [Related]

  • 3. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J.
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [Abstract] [Full Text] [Related]

  • 4. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [Abstract] [Full Text] [Related]

  • 5. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 6. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 7. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S, Cakar B, Conkbayir I, Hekimoglu B.
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [Abstract] [Full Text] [Related]

  • 8. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ, Mangold LA, Epstein JI, Partin AW.
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [Abstract] [Full Text] [Related]

  • 9. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR, Remzi M, Snow PB, Schulman CC, Marberger M, Djavan B.
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [Abstract] [Full Text] [Related]

  • 10. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
    Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH.
    J Urol; 1997 Jun; 157(6):2191-6. PubMed ID: 9146612
    [Abstract] [Full Text] [Related]

  • 11. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D, Kamil ST, Pakasi LS.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [Abstract] [Full Text] [Related]

  • 12. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate.
    Presti JC, Carroll PR.
    Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples.
    Egawa S, Suyama K, Matsumoto K, Kuwao S, Baba S.
    J Urol; 2002 Jan; 167(1):97-102. PubMed ID: 11743284
    [Abstract] [Full Text] [Related]

  • 14. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
    Huland H, Hammerer P, Henke RP, Huland E.
    J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
    [Abstract] [Full Text] [Related]

  • 15. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A, Dworschack RT, Partin AW.
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [Abstract] [Full Text] [Related]

  • 16. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
    Ohori M, Dunn JK, Scardino PT.
    Urology; 1995 Nov; 46(5):666-71. PubMed ID: 7495118
    [Abstract] [Full Text] [Related]

  • 17. Significance of serum free prostate specific antigen in the screening of prostate cancer.
    Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T.
    J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.
    Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ.
    J Urol; 2000 Aug; 164(2):388-92. PubMed ID: 10893592
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY.
    Urol Int; 2009 Aug; 82(3):270-5. PubMed ID: 19440012
    [Abstract] [Full Text] [Related]

  • 20. T1c prostate cancer detection rate and pathologic characteristics: comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population.
    Park HK, Hong SK, Byun SS, Lee SE.
    Urology; 2006 Jul; 68(1):85-8. PubMed ID: 16806412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.